Apichat Kaewdech Selected Research

Hepatitis B Surface Antigens (HBsAg)

9/2023	HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.
1/2022	Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up.
1/2022	HBV seroprevalence and liver fibrosis status among population born before national immunization in Southern Thailand: Findings from a health check-up program.
1/2022	Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE).
1/2022	Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.
12/2020	Hepatitis B surface antigen, core-related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Apichat Kaewdech Research Topics

Disease

6	Chronic Hepatitis B 09/2023 - 12/2020
5	Fibrosis (Cirrhosis) 01/2024 - 09/2020
4	Hepatitis B 01/2022 - 12/2020
3	Liver Diseases (Liver Disease) 05/2024 - 01/2022
3	Infections 11/2023 - 01/2022
2	Non-alcoholic Fatty Liver Disease 11/2023 - 09/2022
2	COVID-19 09/2023 - 01/2022
1	Acute-On-Chronic Liver Failure 05/2024
1	Stomach Neoplasms (Stomach Cancer) 04/2024
1	Gastritis 04/2024
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2024
1	Autoimmune Hepatitis 01/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023
1	Hepatitis 09/2023
1	Neoplasms (Cancer) 09/2022
1	Hyperlipidemias (Hyperlipidemia) 09/2022
1	Diarrhea 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Esophagitis 09/2020
1	Ulcer 09/2020
1	Primary Myelofibrosis (Myelosclerosis) 07/2018
1	Hyperpigmentation 07/2018
1	Pain (Aches) 01/2018
1	Fever (Fevers) 01/2018
1	Malignant Pleural Effusion 01/2018

Drug/Important Bio-Agent (IBA)

6	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2023 - 12/2020
5	Antiviral Agents (Antivirals)IBA 09/2023 - 09/2021
4	AntigensIBA 01/2022 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 08/2023
2	Hepatitis B e AntigensIBA 09/2023 - 08/2023
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2020
1	Virulence Factors (Pathogenicity Factors)IBA 04/2024
1	Proton Pump InhibitorsIBA 11/2023
1	mRNA VaccinesIBA 09/2023
1	COVID-19 VaccinesIBA 09/2023
1	VaccinesIBA 09/2023
1	Branched-Chain Amino AcidsIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2022
1	ABO Blood-Group SystemIBA 11/2021
1	Interferon-alpha (Interferon Alfa)IBA 11/2021
1	BilirubinIBA 09/2020
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 09/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 07/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2018
1	Talc FDA Link 01/2018
1	TabletsIBA 01/2018
1	Sclerosing Solutions (Sclerosing Agents)IBA 01/2018
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018

Therapy/Procedure

9	Therapeutics 09/2023 - 07/2018
3	Liver Transplantation 05/2024 - 01/2022
1	Retreatment 08/2023
1	Enteral Nutrition (Feeding, Tube) 01/2022
1	Length of Stay 01/2018
1	Pleurodesis 01/2018